DFDA

Antibiotics (e.g., Piperacillin-tazobactam)

Treatment for Gallbladder And Biliary Diseases

Typical Dosage: Piperacillin-tazobactam 3.375g IV q6h

Effectiveness
90%
Safety Score
70%
Clinical Trials
1
Participants
100K

Comparative Safety Scale(Higher is safer)

Cyanide☠ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
Piperacillin-tazobactam 3.375g IV q6h
Time to Effect
1-3 days
Treatment Duration
7-14 days per episode
Evidence Quality
HIGH
Number Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$1,500
Monitoring:$100
Side Effect Mgmt:$200
Total Annual:$5,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.6
Outcome-Based Costs
Cost per Responder
$5,556
Prescription Access Economics
Risk Assessment
Misuse Risk
MODERATE
Missed Diagnosis Risk
LOW
Requires Monitoring
Yes
Needs lab work/checkups
Antibiotics (e.g., Piperacillin-tazobactam) Outcomes

for Gallbladder And Biliary Diseases

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+90%
Common Side Effects
Nausea and vomiting
+15%
Diarrhea
+20%
Allergic reaction (rash)
+3%
Clostridioides difficile infection
+2%

Sources:

surgeon.co.za
oup.com
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov